Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals

Página do item simplificado
dc.creatorWanessa Miranda-Silva
dc.creatorMarco Aurélio Montezuma
dc.creatorBernar Monteiro Benites
dc.creatorJulia Stephanie Bruno
dc.creatorFelipe Paiva Fonseca
dc.creatorEduardo Rodrigues Fregnani
dc.date.accessioned2024-01-31T17:44:14Z
dc.date.accessioned2025-09-08T22:58:18Z
dc.date.available2024-01-31T17:44:14Z
dc.date.issued2020-03-06
dc.identifier.doihttps://doi.org/10.1007/s00520-020-05374-4
dc.identifier.issn09414355
dc.identifier.urihttps://hdl.handle.net/1843/63562
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofSupportive care in cancer
dc.rightsAcesso Aberto
dc.subjectBisphosphonate-associated osteonecrosis of the jaw
dc.subjectHealth personnel
dc.subjectPharmaceutical preparations
dc.subjectOsteonecrosis
dc.subjectSurveys and questionnaires
dc.subjectMedical oncology
dc.subjectNeoplasms
dc.titleCurrent knowledge regarding medication-related osteonecrosis of the jaw among different health professionals
dc.typeArtigo de periódico
local.citation.epage5404
local.citation.spage5397
local.citation.volume28
local.description.resumoPurpose To assess the current knowledge regarding medication-related osteonecrosis of the jaw (MRONJ); the adverse effects of anti-resorptive (AR) and anti-angiogenic (AA) drugs; strategies for MRONJ prevention and treatment; and perception of the dentist’s role in assisting patients who use these drugs among physicians, dentists, and nurses. Methods Using questionnaires, the current knowledge of MRONJ was assessed among dentists, physicians, and nurses, who were divided into group I, which included specialties that directly assist cancer patients, and group II, which included other specialties. The questionnaires assessed the characteristics of the health professionals, training time, and specialties; their knowledge of AR and AA drugs; and their knowledge of MRONJ. Results A total of 1370 health professionals participated in the study, including 1032 dentists, 239 physicians, and 99 nurses. Among dentists and physicians, the training time (p = 0.036 and p < 0.001, respectively) and specialization in group I domains (p < 0.001 and p < 0.001, respectively) had a significant impact on MRONJ knowledge, while nurses showed no significant impact regardless of the training time and specialty. Less than 10% of the physicians and dentists could correlate the signs and symptoms of all stages of MRONJ. Conclusion The findings indicated a notable lack of knowledge regarding MRONJ among dental surgeons and physicians, and especially among nurses. More experienced professionals and specialists in the areas that assist cancer patients usually have a greater understanding of the dentist’s role in MRONJ prevention, diagnosis, treatment, and patient care and will introduce or are already using AR and AA drugs.
local.publisher.countryBrasil
local.publisher.departmentFAO - DEPARTAMENTO DE CLÍNICA
local.publisher.initialsUFMG
local.url.externahttps://link.springer.com/article/10.1007/s00520-020-05374-4

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição:
Baixar

Coleções

Artigo de Periódico

Logo UFMG